To allow the identification of liver cancer patients that express GPC3, and to visualize the tumor size and locations, we developed a new diagnostic imaging probe by conjugating the standard magnetic resonance imaging (MRI) contrast agent to a highly specific chimeric anti-GPC3 antibody. The gene discussed is GPC3; the disease is neoplasm.